SecBot SecBot
PTAB-TRIAL ·Filed Nov 16, 2026

TSLA

Tesla, Inc.
NEUTRAL
Impact 2/10
Processed5h 23m ago PTABPTAB Decision
PTAB institution decision (instituted)

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 PTAB decision.

DocumentAccession Number
PTAB-TRIAL Data (Synthetic)ptab-IPR2026-00382-ins-TSLA

Track record

39 reports on TSLA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +11.68% at T+20 after the Apr 23, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 20261d ago PTAB Trial Neutral 2/10 Entry $378.66 Now $379.74 +0.28% settles Nov 24
  2. Nov 16, 20261d ago PTAB Trial Neutral 2/10 Viewing Entry $378.66 Now $379.74 +0.28% settles Nov 24
  3. Nov 16, 20261d ago PTAB Trial Neutral 3/10 Entry $378.66 Now $379.74 +0.28% settles Nov 24
  4. Nov 16, 20261d ago PTAB Trial Neutral 2/10 Entry $378.66 Now $379.74 +0.28% settles Nov 24
  5. Nov 16, 20261d ago PTAB Trial Neutral 2/10 Entry $378.66 Now $379.74 +0.28% settles Nov 24
  6. Nov 16, 20261d ago PTAB Trial Neutral 2/10 Entry $378.66 Now $379.74 +0.28% settles Nov 24
  7. Nov 9, 20267d ago DEFA14A Neutral 2/10 Entry $379.78 Now $379.74 −0.01% settles Nov 17
  8. Nov 6, 202610d ago DEFA14A Neutral 2/10 Entry $378.05 to $379.74 Now $379.74 +0.45% ▲ +0.45% +2.14% vs SPY
  9. Nov 4, 202613d ago Court Ruling Neutral 2/10 Entry $343.69 to $397.45 Now $379.74 +10.49% ▲ +15.64% +12.35% vs SPY
  10. Nov 3, 202614d ago Court Ruling Neutral 2/10 Entry $385.19 to $390.84 Now $379.74 −1.41% ▲ +1.47% +2.38% vs SPY
Showing 10 of 39

US Market Status

Market Closed · Opens Wed (10h 11m)

Subscribe to SecBot

Get Real-Time PTAB Decision Intelligence

Market-moving PTAB patent decisions analyzed within minutes. Trial institutions, denials, final written decisions, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh TSLA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access